Devyser Diagnostics AB (DVYSR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.034x

Based on the latest financial reports, Devyser Diagnostics AB (DVYSR) has a cash flow conversion efficiency ratio of 0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr12.10 Million ≈ $1.30 Million USD) by net assets (Skr357.90 Million ≈ $38.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Devyser Diagnostics AB for the company's overall valuation and market capitalisation.

Devyser Diagnostics AB - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Devyser Diagnostics AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Devyser Diagnostics AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Devyser Diagnostics AB ranked by their cash flow conversion efficiency. Explore cash flow quality index of Devyser Diagnostics AB to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Phinergy Ltd TA:PNRG	-0.265x
Charlton Aria Acquisition Corporation Class A Ordinary Shares NASDAQ:CHAR	-0.003x
Meridia Real Estate III Socimi SA MC:YMRE	0.044x
Rani Therapeutics Holdings Inc NASDAQ:RANI	-0.183x
Her Chee Industrial Co Ltd TWO:8937	-0.012x
Catur Sentosa Adiprana Tbk JK:CSAP	0.036x
Lexinfintech Holdings Ltd NASDAQ:LX	0.081x
Woongjin Co Ltd KO:016880	0.275x

Annual Cash Flow Conversion Efficiency for Devyser Diagnostics AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Devyser Diagnostics AB from 2018 to 2025. View Devyser Diagnostics AB share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr354.30 Million ≈ $38.13 Million	Skr8.20 Million ≈ $882.45K	0.023x	+117.26%
2024-12-31	Skr349.00 Million ≈ $37.56 Million	Skr-46.80 Million ≈ $-5.04 Million	-0.134x	+25.91%
2023-12-31	Skr385.10 Million ≈ $41.44 Million	Skr-69.70 Million ≈ $-7.50 Million	-0.181x	-92.80%
2022-12-31	Skr431.44 Million ≈ $46.43 Million	Skr-40.50 Million ≈ $-4.36 Million	-0.094x	-137.32%
2021-12-31	Skr416.68 Million ≈ $44.84 Million	Skr-16.48 Million ≈ $-1.77 Million	-0.040x	-294.14%
2020-12-31	Skr30.77 Million ≈ $3.31 Million	Skr627.00K ≈ $67.48K	0.020x	-94.85%
2019-12-31	Skr37.01 Million ≈ $3.98 Million	Skr14.63 Million ≈ $1.57 Million	0.395x	+96.80%
2018-12-31	Skr29.97 Million ≈ $3.23 Million	Skr6.02 Million ≈ $647.85K	0.201x	--

About Devyser Diagnostics AB

ST:DVYSR Sweden Medical Devices

Market Cap

$96.66 Million

Skr898.19 Million SEK

Market Cap Rank

#19405 Global

#341 in Sweden

Share Price

Skr53.50

Change (1 day)

-2.37%

52-Week Range

Skr53.50 - Skr157.00

All Time High

Skr157.80